Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Schroder Ventures' funds and Goldman Sachs Capital Partners agree to purchase nutritionals, ingredients and chemicals arm of Henkel KgaA for $2.37 bil. ([Euro]1=$.91) before year-end, firms announce Sept. 13. Cognis, headquartered in Roermond, Holland, will retain current management team and continue to focus on natural oils, which Schroder and Goldman Sachs view as business growth platform. During first half of 2001, Cognis' sales grew 4% to $1.37 bil.; firm generated sales of $2.91 bil. in 2000. Schroder, Goldman Sachs anticipate continued sales growth of at least 6%-7% per year. Firms expect agreement will be finalized by end of November, however, due to market uncertainty after terrorist attacks in U.S., Henkel has granted the two suitors the absolute right to withdraw from the deal within two months

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts